Wheeze/asthma exacerbation workflow
Primary care wheeze workflow for rapid severity framing, escalation triggers, and controller-plan reinforcement.
High-risk workflowLast reviewed September 4, 2026
AI-assisted evidence review. Clinical-owner sign-off is not recorded for this update.
Scope
- Use for
- Outpatient initial management of wheeze/asthma symptoms in patients without immediate respiratory failure signs.
- Not for
- Severe respiratory distress, hypoxia, or exhaustion requiring emergency pathway.
- Inpatient-level acute asthma management.
Immediate actions
- Record respiratory rate, pulse, oxygen saturation, speech, work of breathing and air entry; repeat after treatment. Assess prior ICU care, recent steroid courses and reliever response.
- Consider anaphylaxis, foreign body and other causes of wheeze. Infant bronchiolitis needs a separate age-specific pathway.
Red flags: escalate now
If any of these are present, stop routine steps and follow the urgency stated. Activate emergency care for instability or findings that need immediate transfer.
- Call emergency services for silent chest, exhaustion, impaired consciousness, cyanosis or marked distress; begin stabilization while transfer is arranged.
- Persistent hypoxemia or poor bronchodilator response requires emergency assessment. In children, SpO2 below 92% needs urgent oxygen and acute-care management; a reassuring saturation alone does not establish mild disease.
First-line plan
- Give inhaled rapid bronchodilator treatment using the age-specific acute asthma protocol; MDI with spacer is preferred when feasible. Do not substitute routine as-needed dosing for an exacerbation protocol.
- Moderate or severe attacks need early systemic corticosteroid assessment and monitored care; do not delay transfer for office investigations.
- Review technique and adherence. Before discharge, prescribe or optimize an inhaled corticosteroid-containing plan appropriate to age and prior treatment; daily low-dose ICS plus as-needed SABA is the CTS first-line approach to mild asthma. Other regimens require age-specific selection.
Follow-up and monitoring
- Discharge only after sustained clinical improvement with a feasible reliever schedule and reliable access to care.
- Provide a written action plan, arrange early reassessment for residual symptoms and complete a control review within 4 weeks in children. Children needing reliever more often than every 4 hours after discharge require reassessment.
- Review persistent symptoms or more than 2 reliever doses per week for inadequate control.
Linked resources
Prescribing aids
Patient handouts
Referral checklists
Condition guidance
Before the patient leaves
Return precautions you can say as written:
“If symptoms get worse, new warning signs appear, or you cannot follow the plan from this visit, seek urgent care now.”
About this workflow
- Clinical owner
- Family Medicine Editorial Team
- Risk tier
- High
- Review cadence
- Every 3 months
- Last reviewed
- September 4, 2026AI-assisted evidence review. Clinical-owner sign-off is not recorded for this update.
- Review status
- Evidence current. Next review due December 4, 2026.